This study compares mesenchymal cells isolated from excised burn wound eschar with adipose-derived stem cells (ASCs) and dermal fibroblasts in their ability to conform to the requirements for multipotent mesenchymal stem cells (MSCs). A population of multipotent stem cells in burn eschar could be an interesting resource for tissue engineering approaches to heal burn wounds. Cells from burn eschar, dermis, and adipose tissue were assessed for relevant CD marker profiles using flow cytometry and for their trilineage differentiation ability in adipogenic, osteogenic, and chondrogenic conditions. Although the different cell types did not differ significantly in their CD marker expression, the eschar-derived cells and ASCs readily differentiated into adipocytes, osteoblasts, and chondrocytes, while dermal fibroblasts only exhibited some chondrogenic potential. We conclude that the eschar-derived mesenchymal cells represent a population of multipotent stem cells. The origin of the cells from burn eschar remains unclear, but it is likely they represent a population of adult stem cells mobilized from other parts of the body in response to the burn injury. Their resemblance to ASCs could also be cause for speculation that in deep burns the subcutaneous adipose tissue might be an important stem cell source for the healing wound.
INTRODUCTION
enormous number of different scaffold materials developed recently, fundamental knowledge about exact composition and architecture necessary for skin tissue engineering is Due to the progression in burn wound care of recent decades the percentage of patients surviving their burn still scarce. Hence, clinical improvements on the conventional split skin graft treatment are limited (32) . injury has greatly increased. The increased survival rate has also increased the number of people who are left
The choice of cells for skin tissue engineering is also vital to the outcome of the wound healing process. with burn scars that are often cause for great functional problems due to contractures. Also their disfigurement Autologous healthy skin cells would obviously be preferable and some significant results have been achieved can cause psychosocial problems (33). These developments have induced new research into wound healing in supplying epidermal cells to wounds (5,35). Providing dermal cells for tissue engineering is more problematic, with a focus on the prevention/reduction of scar formation. The most promising approach to these problems is as conventional split skin grafts contain only a small dermal component. This obviously adds to the more tissue engineering, which aims at rebuilding the lost skin. This is achieved by applying differentiated skin well-known problems of skin grafting, namely that the creation of additional wounds as donor sites is not ideal cells or stem cells to a scaffolding material that will induce those cells to organize into a normal skin configas it is associated with pain and morbidity; furthermore, in extensive burns donor sites might be limited. uration. Two major problems with the tissue engineering approach are the scaffold design and the source of cells.
The discovery of adult stem cells in different tissues in recent years has provided researchers with an alternative The scaffold should create a microenvironment that will guide the cells towards tissue regeneration. Despite the source of cells for tissue engineering purposes without having to disturb the patients remaining healthy skin. It healthy donors during abdominal dermolipectomy. A split skin biopsy 0.3 mm in thickness was removed has been shown that mesenchymal stem cells (MSCs) isolated from bone marrow can be used to stimulate using a dermatome (Aesculap AG & Co. KG, Tuttlingen, Germany). Subcutaneous fat samples were cut from the wound healing (9,11,36). However, the harvesting of stem cells from bone marrow is a painful procedure that material using sterile scissors. Eschar material was obtained from patients undergoing burn treatment in the yields only limited amounts of multipotent cells. Recently attention has turned more towards stem cells isolated burn center of the Red Cross Hospital Beverwijk, Netherlands. Eschar tissue was removed between 11 and from subcutaneous fat, which is far more abundant, easily accessible, and yields higher numbers of multipotent 26 days post-burn injury. All tissue was obtained in accordance with the guidelines of the Red Cross Hospicells than bone marrow (39) . These adipose-derived stem cells (ASCs) have been tested in a variety of in tal, Beverwijk and according to the code of proper use of human tissue formulated by the federation of Dutch vitro and in vivo models resembling various injuries. They were shown to improve the healing process commedical scientific societies (FMWV/FDMSS). Cells were isolated from the different types of tissue pared to control treatments (21) . With regard to wound healing, experiments have mainly focused on the wound as described previously (31) . Dermis and epidermis were separated enzymatically by incubating in a saline closure time in rodents, where it was shown that ASCs were able to improve the rate of wound closure (1, 14, 24) . solution with 0.25% dispase II (Boehringer Mannheim, Germany) at 37°C for 1 h. Dermal, fat, and eschar tisBurn eschar is the nonviable tissue that remains after a burn injury. This tissue is essentially dead and surgical sues were washed, weighed, and minced with sterile scissors. Materials were then incubated for 1.5-3 h in 2 removal of the eschar is known to decrease the incidence of infection, reduce the inflammatory response, and ml of saline containing 0.25% dispase II/collagenase A (Boehringer, Mannheim, Germany) for every gram of improve the outcome of the wound healing process (4,12). Our laboratory has isolated mesenchymal cells tissue at 37°C under continuous agitation. The resulting suspension was passed through a filter chamber from eschar tissue after debridement of a burn wound and proposed to use this cell population for tissue engi-(Beldico, Duiven, Netherlands) and washed with 1% fetal calf serum (FCS; Hyclone, Logan, UT) in phosneering purposes (34). Our research into these escharderived mesenchymal cells revealed that they were phate-buffered saline (PBS; Gibco, Pastley, UK). Cells were pelleted, suspended in fibroblast culture medium highly similar to mesenchymal cells derived from subcutaneous fat in both α-smooth muscle actin (α-SMA) (FBM) [DMEM with 10% FCS, 1 mM L-glutamine, 100 µg/ml streptomycin, and 100 IU/ml penicillin (Gibco, expression and their ability to contract collagen scaffolds in vitro. Also fluorescence-activated cell sorting Pastley UK)] passed through a 0.7-µm cell strainer (Fischer, Landsmeer, Netherlands), pelleted again, and (FACS) analysis did not reveal differences between the two populations (31) . The mesenchymal cells derived seeded at approximately 20,000-30,000 cells/cm 2 . One day after isolation the cells were washed with PBS and from subcutaneous fat, described in the latter article, were later identified as stem cells (39) . We suspect that fresh culture medium was added. Cell passage was performed using trypsin (Gibco, Pastley, UK) just prior to the mesenchymal cells isolated from burn eschar might actually also be MSCs that have migrated into the reaching full confluence. In total 13 cell populations isolated from dermis (age: wound area from the subcutaneous fat or another source of MSCs after burn injury.
26-51 years, mean: 38 years), 9 from adipose tissue (age: 33-51 years, mean: 42 years), and 12 from eschar In this study we investigated whether eschar-derived cells fulfill all the criteria, formulated by the Internatissue [age: 8 months-79 years, mean: 38 years, total body surface area (TBSA): 0.5-19%, mean: 4%, eschar tional Society for Cellular Therapy (ISCT) for multipotent mesenchymal stromal cells. We assessed the excision post burn: 11-26 days, mean: 14 days] were used in this study. differentiation potential of mesenchymal stromal cells isolated from normal dermis, adipose, and burn eschar For flow cytometry, the following number of populations were analyzed: dermis (n = 10), adipose (n = 8), tissue and examined these cell types for an array of cluster of differentiation (CD) markers that have been postueschar (n = 7). For general trilineage differentiation: dermis (n = 3), adipose (n = 4), eschar (n = 4). For micromass lated to be indicative of multipotent mesenchymal stromal cells (8).
culture: dermis (n = 3), adipose (n = 3), eschar (n = 4).
MATERIALS AND METHODS

Flow Cytometry Tissue Handling and Cell Culture
After three passages cells were labeled with fluorescently labeled specific antibodies (Table 1) for flow Mesenchymal cells derived from dermis and subcutaneous fat were isolated from tissue obtained from cytometry. Cells were trypsinized and washed in facs buffer (0.1% bovine serum albumin; Sigma-Aldrich, St. biotec, Bergisch Gladbach, Germany) and FBM. Medium was changed twice a week, and the resulting cell mass Louis, MO) and 0.05% sodium-azide in PBS). Samples were then incubated with the antibodies in Table 1 for was fixed in 4% formalin for 24 h after 3 weeks of culture, dehydrated, and embedded in paraffin for histologi-30 min at 2-8°C. Afterwards cells were washed with FACS buffer twice and stored in FACS buffer until being cal examination. measured on a Facscalibur flow cytometer (BD BiosciStaining for Differentiated Cells ences, San Jose, CA), within 24 h after labeling. Cells
Staining for differentiated cells was adopted from were kept on ice or at 2-8°C during the whole procedure.
earlier protocols with some minor adjustments (30,39 in chondrogenic differentiation medium [DMEM, 1% definitions. They are positive for CD90, CD105, and CD73 and negative for CD31, CD45, CD14, CD79a, FCS, 6.25 µg/ml insulin, 10 ng/ml transforming growth factor-β1 (TGF-β1), 50 nM ascorbate-2-phosphate, 1%
and human leukocyte antigen (HLA)-DR. However, a small percentage of cells was found to express CD34. antibiotics, as described in Zuk et al. (39) ]. RNA was isolated using TRIzol reagent (Invitrogen Life TechnolThis resembled a small shift of the population and not a clearly positive subpopulation of cells. Differences in ogies, Breda, The Netherlands) according to the manufacturer's instructions.
CD34 expression did not seem to be correlated with donor age, time between burn, and eschar removal or Real-Time RT-PCR Assays. RNA (500 ng) was reverse total body surface area (TBSA). transcribed using the QIAGEN QuantiTect reverse Table 2 presents the mean positive percentages transcription kit according to the manufacturer's instruccalculated by Overton histogram subtraction for each tions. The resulting cDNA was diluted to 100-µl and 5-CD marker. µl samples, which were used for amplification in PCR Figure 1A -D shows representative histogram profiles reaction.
of ASCs and eschar-derived cells as well as examples Real-time RT-PCR was performed using the iQ of variation in CD34 expression between samples of the SYBRgreen Supermix (Bio-Rad, Veenendaal, The Nethsame cell type. erlands). cDNA was amplified using specific collagen 2a1 primers (forward: GGAGCAGCAAGAGCAAG GAGAAG; reverse: TGGACAGCAGGCGTAGGAAGG) Differentiation at a concentration of 0.40 µM, in an iCycler iQ thermal Differentiation was assessed through four different cycler (Bio-Rad). After activating the DNA polymerase stains. Alcian blue (pH 1.0) stains highly sulfated mucoby incubation for 2 min at 95°C, 40 cycles of amplificasubstances, which are one of the main components of tion (95°C for 30 s and 55°C for 60 s) were performed.
cartilage and are used to demonstrate the presence of Fluorescence was monitored during every thermal cycle chondrocytes. Alkaline phosphatase is usually found in at the 55°C annealing step. After PCR, the baseline subliver or bone tissue and used along von Kossa staining to traction method was used to determine the threshold cycle.
Data are expressed as ratios between target mRNA and housekeeping genes β2-microglobulin (forward: which is set at 1. Data are displayed in box plots. The median value, and the bars the highest and lowest value. already demonstrated that although FACS analysis performed with the described CD markers show a more or However, micromass culture of these cells did produce some positive Alcian blue staining, indicative of chonless homogenous cell population, only a small percentage of these cells are multipotent stem cells (13). These drogenic differentiation capability. Figure 2 shows representative images of the different results show that flow cytometry data need to be accompanied by trilineage differentiation to determine whether stains performed to establish differentiation. a cell population contains MSCs. Further research will Collagen 2a1 RT-PCR be needed to identify, to date undiscovered, discriminating markers or a more refined set of known CD markers PCR results are displayed in Figure 3 . All three cell types used in this study expressed significantly more that will successfully identify MSCs without the need for differentiation experiments. collagen 2 RNA when cultured in chondrogenic differentiation medium compared to FBM control samples MSCs exhibit a contractile phenotype. In studies culturing bone marrow-derived mesenchymal stem cells (Mann-Whitney p < 0.05).
(BMSCs) on dermal scaffolds (25) as well as in our own DISCUSSION experiences with ASCs and BESCs in such applications (31) , the cells contract the scaffold and are found to In this article we describe that the mesenchymal cells isolated from burn eschar meet the criteria of multipoexpress αSMA. In human wound healing, contraction and αSMA expression are associated with myofibroblast tent mesenchymal stromal cells as defined by the ISCT (8). Cells isolated from dermal tissue showed limited differentiation. These cells are generally associated with poor wound healing, as they produce excessive and differentiation capacity, even though they did match the required CD marker profile. ASCs did not perform difabnormal extracellular matrix (ECM) and are held responsible for the contractures often seen in hypertroferent from the eschar-derived cells in any of the experiments performed in this study. Therefore, we refer to phic scars (6). Even though αSMA expression is not a definitive marker of myofibroblasts, contraction data the eschar-derived cells as burn eschar-derived mesenchymal stem cells (BESCs).
suggest that mesenchymal stromal cells are able to differentiate into myofibroblasts. On the other hand, Quirici et al. linked CD271 expression on ASCs to increased proliferation and differentiation potential (23) .
αSMA expression could be a property of MSCs unrelated to myofibroblast differentiation. Strikingly, all We included CD271 in our analysis to see if we could identify a CD271-positive population in our cell popmultipotent mesenchymal cell populations that seem to have a high differentiation potential contain high perulations. In all three of our cell populations CD271 expression was very low (1-2%) but nevertheless the centages of αSMA-positive cells. Suga et al. also reported that CD34-negative ASCs displayed greater differentiation potential of the ASCs and BESCs could be established. CD34 expression varied widely between differentiation potential than CD34-positive ASCs, as well as increased αSMA RNA expression, suggesting a cells isolated from different types of tissue. However, variation was also observed between different samples link between increased αSMA expression and differentiation potential (26) . of cells isolated from the same type of tissue. Changes in CD34 expression were always observed as shifts in
The origin of the BESCs is open to speculation. The eschar tissues used in this study were excised between the mean fluorescence of the entire cell population and not as distinct positive and negative populations.
11 and 26 days after the burn injury. This is done to allow partial thickness burns to heal without the need According to the ISCT criteria MSCs should not express CD34 as this is a hematopoietic cell marker. However, for skin grafts, according to the policy of many European burn centers. Delayed surgical excision combined the gradual loss of CD34 expression by ASCs in culture is an often observed phenomenon (2, 20, 27, 37) . A recent with specific topical treatment is a regular treatment option in the Netherlands. During this period the study has established that although CD34 expression is correlated with differences in proliferation and differennecrotic tissue or the severely damaged tissue could attract (stem) cells from the surrounding tissues, through tiation potential, it is not a marker that is essential to the chemokine secretion by inflammatory cells, in an closure of the defect, as they possess the myofibroblast phenotype that plays an important role in ECM producattempt to heal the defect. The BESCs could possibly be ASCs or another adult population of MSCs migrating tion and wound contraction. We have tried to isolate BESCs from some early excisions that are performed in from their respective tissues to the site of the burn injury. Several studies have shown that stem cells from our local burn center, but have been unable to detect them in reasonable numbers in these eschar samples. bone marrow seem to be able to home to the wound area and integrate in the regenerated skin, both in the dermis Although we have not determined at what time postburn BESCs generally appear, this suggests that it might take and epidermis (10,24,36). Elevated levels of circulating MSCs have also been detected in the blood of burn vicsome time for them to migrate into the burned tissue. It is very well possible that the influx of BESCs continues tims (17) . However, a recent study has demonstrated that bone marrow-derived cells probably do not contribafter excision of the eschar and that these cells will influence the healing process also after the application ute to the fibroblast and myofibroblast population of a healing wound in mice (3). But the subcutaneous adiof the skin graft. Regardless of the timing of influx of these cells, we think this finding represents an interestpose tissue could still be considered a potential source of multipotent mesenchymal cells, which could play a ing option for novel wound treatment, because it offers the possibility to isolate the BESCs from a late excision role in the healing of deep skin wounds.
Evidence for the involvement of the subcutaneous fat eschar and use them in tissue engineering applications for burn wounds. in wound healing is provided by the presence of fat domes in anatomical locations prone to hypertrophic MSCs can only be expected to be beneficial to tissue regeneration if they differentiate into the locally required scarring (18) . The role BESCs play in wound healing is unclear, as is the timing of the influx into the wound phenotype in the wound environment. If the correct signals from normal skin are absent the application of area. It is very likely that these cells contribute to the
